Positive context积极背景
Stocks股票 / Health Care / EXEL
Exelixis · Health Care
EXEL US listed · USD美股 · 美元
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of...Exelixis, Inc. 是一家位于加利福尼亚州阿拉米达的基因组学药物研发公司，其产品Cometriq已获美国食品药品监督管理局批准用于治疗甲状腺髓样癌，并对多种其他类型转移性癌症具有临床活性。
Large cap大盘 · $15B
Health Care
S&P 400标普400中盘
Rate-sensitive利率敏感
$58.16
+$0.21 · +0.36%
52w low52周低 $33.73high高 $60.18
Neutral — no clear edge中性 — 无明显优势
Trend intact — hold. Late in the cycle, so don't add here; a pullback is due.趋势完好——持有。已处周期晚期，此处不宜加仓；回调即将到来。
As of 2026-09-29截至 2026-09-29
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-29
Momentum (RSI 14)动量（RSI 14）
56
Neutral zone中性区域
vs 50-day average相对50日均线
+4.7% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+19.5% above上方
Long trend up长期向上
Volatility波动率
32th percentile第32百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0336
Estimates being cut预期下调
Beat expectations 4 quarters in a row连续 4 季度超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 17.6%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | EXEL | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 19.51x | 29.58 | |
| P/B市净率 | 7.06x | 3.30 | |
| P/S市销率 | 6.58x | 3.19 | |
| Earnings yield盈利收益率 | 5.13% | 2.56 | |
| FCF yield自由现金流收益率 | 5.74% | 4.11 | |
| Shareholder yield股东收益率 | 6.21% | 1.87 | |
| EV/EBITDA企业价值/EBITDA | 16.40x | 18.26 | |
| P/FCF市值/自由现金流 | 17.43x | 21.34 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$2.3B2025
20202025
5-yr growth5年复合增速 18.6%
Earnings per share每股收益
$2.782025
20202025
5-yr growth5年复合增速 51.4%
Free cash flow自由现金流
$875.8M2025
20202025
Operating margin营业利润率
37.6%
Net margin净利率
33.7%
FCF margin自由现金流利润率
38.1%
Balance-sheet quality财务体质 6/8
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 36%
Clean稳健
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.54
Current ratio流动比率3.56
Capital allocation资本配置
Buybacks (TTM)回购（TTM）$947.5M
Stock-based comp股权薪酬$113.0M
Share count change (1y)股数变化（1年）-6.8%
Debt coming due到期债务
FY2016 10-KIn the 12-month bucket following fiscal period end 2016-12-31, it reported $80.0M due — about 39% of its disclosed principal.在财年期末 2016-12-31 之后12个月的区间内，已披露到期本金为 $80.0M，约占其披露本金的 39%。
All maturity buckets are measured from fiscal period end 2016-12-31, not from today.所有到期区间均从财年期末 2016-12-31 起算，而非从今天起算。
First 12 months after period end报告期末之后首12个月
$80.0M
Year 2第2年
$125.0M
Year 3第3年
not reported未披露
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
Cash reported at 2026-01-02: $482488000.截至 2026-01-02 披露的现金：$482488000。 Operating cash flow exceeded or equaled equipment spending over 2025-01-04 to 2026-01-02; no cash burn to measure.在 2025-01-04 至 2026-01-02 期间，经营现金流不低于设备支出，无可衡量的现金消耗。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实，不跨文件拼接。文件
0000939767-17-000019, period ending报告期截至 2016-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-24T08:02:22.589681+00:00.
2/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive— period_mismatch
Annual period年度区间 2025-01-04 — 2026-01-02 · USD · 10-K · 0000939767-26-000021 · Filed提交日期 2026-02-10.
Cache acquired缓存获取时间: 2026-09-24T08:02:22.589681+00:00 · Evaluated as of评估截至 2026-09-29.
- Reported operating cash flow已披露经营活动现金流: $884267000
- Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $8429000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $875838000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
EXEL daily MACD crossed downEXEL 日线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$31.2M net (0 buyers, 11 sellers)-$31.2M 净值（0 买家，11 卖家）
Signal history信号历史
engine events引擎事件
UNCONFIRMED TURN → UPTREND未确认转向 → 上涨趋势
HOLD. The weekly (investor-cycle) momentum just crossed UP while price holds its 10-day average — the start of a new multi-month up-leg. A daily-overbought print here is the launch thrust, not a top, so this is a HOLD / ride, not a take-profit. The daily can still dip to its 10-day average (normal) — but the bigger investor cycle is early, with room left持有。周线（投资者周期）动量刚刚向上交叉，且价格守住 10 日均线——这是新的多月上行段的起点。此处日线超买只是启动推力、并非见顶，因此应持有 / 顺势，而非止盈。日线仍可能回踩 10 日均线（属正常）——但更大的投资者周期尚处早期，仍有空间
Sep 21, 2026
EXEL daily MACD crossed downEXEL 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $57.22.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$57.22。
Sep 18, 2026
BUY ZONE → BOTTOMING买入区 → 筑底中
BUY SETUP买入预备
Sep 18, 2026
EXEL weekly MACD crossed upEXEL 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Sep 17, 2026
UNCONFIRMED TURN → BUY ZONE未确认转向 → 买入区
BUY买入
Sep 17, 2026
EXEL took relative-strength leadershipEXEL 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $58.49.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$58.49。
Sep 17, 2026
EXEL daily MACD crossed upEXEL 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $58.49.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$58.49。
Sep 17, 2026
EXEL StochRSI turned up from oversoldEXEL StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $58.49.StochRSI重回20上方 — 下行动量趋缓的最早预警。$58.49。
Sep 15, 2026
EXEL daily MACD crossed downEXEL 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $56.90.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$56.90。
Sep 11, 2026
UPTREND → UNCONFIRMED TURN上涨趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 11, 2026
EXEL weekly MACD crossed downEXEL 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Sep 10, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Sep 9, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Sep 9, 2026
EXEL took relative-strength leadershipEXEL 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $58.33.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$58.33。
Showing the last 15 of显示最近15条，共 304 signals条信号
Company profile公司档案
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of...Exelixis, Inc. 是一家位于加利福尼亚州阿拉米达的基因组学药物研发公司，其产品Cometriq已获美国食品药品监督管理局批准用于治疗甲状腺髓样癌，并对多种其他类型转移性癌症具有临床活性。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Shareholder payout股东回报
Above market高于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
Watch items — what could change the story关注项 — 可能改变故事的因素
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 19.5× | 29.6× | 77% |
| Price / Book市净率 | 7.1× | 3.3× | 21% |
| Price / Sales市销率 | 6.6× | 3.2× | 23% |
| EV / EBITDAEV/EBITDA | 16.4× | 18.3× | 61% |
| Earnings yield盈利收益率 | 5.1% | 2.6% | 83% |
| Free-cash-flow yield自由现金流收益率 | 5.8% | 5.5% | 56% |
| Shareholder yield股东综合回报率 | 6.2% | 1.9% | 87% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
77/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
74/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
83/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
82/100 — stronger than most强于多数
Rank in sector行业内排名
#47 / 173
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -0.3% | +1.3% |
| 1 Month近1月 | +3.7% | +0.9% |
| 3 Months近3月 | +6.2% | +6.1% |
| 6 Months近6月 | +40.0% | +22.3% |
| Year to date年初至今 | +33.5% | +13.8% |
| 1 Year近1年 | +50.3% | +18.5% |
| 3 Years近3年 | +167.4% | +87.8% |
Trading information交易信息
Beta vs market贝塔
0.58
Volatility rank波动率分位
32th pctile
Short interest空头占比
10.1% of float
Market cap市值
$15B
EPS (trailing)每股收益
$2.98
Off 52-week high距52周高点
-1.6%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $988M | $1.4B | $1.6B | $1.8B | $2.2B | $2.3B |
| EPS每股收益 | $0.35 | $0.72 | $0.56 | $0.65 | $1.76 | $2.78 |
| Free cash flow自由现金流 | $179M | $337M | $335M | $293M | $672M | $876M |
| Gross margin毛利率 | 96.3% | 96.3% | 96.4% | 96.0% | 96.5% | 96.4% |
| Net margin净利率 | 11.3% | 16.1% | 11.3% | 11.4% | 24.0% | 33.7% |
| FCF margin自由现金流利润率 | 18.1% | 23.5% | 20.8% | 16.0% | 31.0% | 37.7% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$2.3B
Net income净利润
$783M
Operating cash flow经营现金流
$884M
Total assets总资产
$2.8B
Shareholder equity股东权益
$2.2B
Buybacks股票回购
$948M
Shares outstanding总股本
0.26B
Returns & growth回报与增长
Return on equity股本回报率
36.2%
Return on assets资产回报率
27.5%
Profit growth利润增速
+50.1%
Asset growth资产增速
-3.5%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Working capital: inventory & receivables lean vs sales营运资本：存货与应收相对销售保持精简
- Pricing power: gross margin +0.1pts over 6 years定价能力：毛利率 6 年上升 0.1 个百分点
- Capital discipline: disciplined growth, returning cash资本纪律：增长克制、回报股东
- Balance sheet: Altman Z 15.64 — safe zone资产负债表：Altman Z 15.64——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
56
RSI (2-day)RSI（2日）
69
vs 20-day average相对20日均线
+1.4%
vs 50-day average相对50日均线
+4.7%
vs 200-day average相对200日均线
+19.5%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down — turning up soon动能向下——接近转强
Weekly周线
momentum up — fresh upturn动能向上——刚刚转强
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
19/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $0.82 | $0.75 | +9.3% |
| Mar 2026 | $0.79 | $0.67 | +17.9% |
| Dec 2025 | $0.88 | $0.68 | +29.4% |
| Sep 2025 | $0.67 | $0.59 | +13.6% |
Estimate revisions预期修正
Analysts covering覆盖分析师
11
Estimate direction预期调整方向
mostly cutting多数下调
Estimate change, 90 days预期变化（90天）
+5.2%
Net upgrades, 30 days净上调（30天）
-1
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$31.2M
Insider buyers vs sellers内部人买家vs卖家
0 : 11
Short interest空头占流通盘
10.1%
Days to cover回补天数
12.4
Short interest change空头变化
-7.9%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Feb · 100%
Weakest month最弱月份
Jan · 33%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -5.3% | 3 |
| Feb2月 | 100% | +6.6% | 3 |
| Mar3月 | 33% | -2.2% | 3 |
| Apr4月 | 67% | +4.0% | 3 |
| May5月 | 67% | +11.9% | 3 |
| Jun6月 | 100% | +3.6% | 3 |
| Jul7月 | 33% | -2.2% | 3 |
| Aug8月 | 100% | +4.2% | 4 |
| Sep9月 | 50% | +6.6% | 4 |
| Oct10月 | 33% | -5.1% | 3 |
| Nov11月 | 100% | +9.6% | 3 |
| Dec12月 | 33% | -0.3% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。